Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS)

被引：2
|
作者：
Vicente, Alana [1 ]
Gutierrez-Rodrigues, Fernanda [1 ]
Giudice, Valentina [1 ]
Wu, Zhijie [1 ]
Kajigaya, Sachiko [1 ]
Ibanez, Maria del Pilar Fernandez [1 ]
Albitar, Maher [2 ]
Weinstein, Barbara [1 ]
Calvo, Katherine R. [1 ]
Townsley, Danielle M. [1 ]
Scheinberg, Phillip [3 ]
Dunbar, Cynthia E. [1 ]
Young, Neal S. [1 ]
Winkler, Thomas [1 ]
机构：
[1] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
[2] NeoGenomics, Valley Ctr, CA USA
[3] Hosp A Beneficencia Portuguesa, Div Hematol, Sao Paulo, Brazil
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-119780
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
229
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Engraftment of Immature Hematopoietic Low Risk Myelodysplastic Syndrome (MDS) Cells in Conjunction with MSCs
    Medyouf, H.
    Nolte, F.
    Mossner, M.
    Nowak, V.
    Zens, B.
    Muedder, K.
    Oblaender, J.
    St Fey
    Klaumuenzer, M.
    Fabarius, A.
    Riedl, E.
    Marx, A.
    Roehl, H.
    Mueller, N.
    Metzgeroth, G.
    Huetter, G.
    Hofmann, W. K.
    Nowak, D.
    Trumpp, A.
    ANNALS OF HEMATOLOGY, 2013, 92 : S59 - S59
  • [42] Eltrombopag in patients with high-risk myelodysplastic syndrome or acute myeloid leukaemia: cautious optimism
    Buckstein, Rena
    LANCET HAEMATOLOGY, 2015, 2 (10): : E396 - E397
  • [43] CLINICAL VALUE OF MONOSOMAL KARYOTYPE AND COMPLEX KARYOTYPE AS PROGNOSTIC PARAMETER IN PATIENTS WITH IPSS INTERMEDIATE-2 AND HIGH RISK MYELODYSPLASTIC SYNDROMES TREATED WITH AZACITIDINE
    Song, M. K.
    Chung, J. S.
    Moon, J. H.
    Ahn, J. S.
    Song, I. C.
    Hong, J.
    Lee, G. W.
    Shin, H. J.
    HAEMATOLOGICA, 2014, 99 : 346 - 346
  • [44] Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM
    Natarajan-Ame, Shanti
    Park, Sophie
    Ades, Lionel
    Vey, Norbert
    Guerci-Bresler, Agnes
    Cahn, Jean-Yves
    Etienne, Gabriel
    Bordessoule, Dominique
    Ravoet, Christophe
    Legros, Laurence
    Cheze, Stephane
    Stamatoullas, Aspasia
    Berger, Elisabeth
    Schmidt, Aline
    Charbonnier, Aude
    Chaury, Marie-Pierre
    Braun, Thorsten
    Fenaux, Pierre
    Dreyfus, Francois
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (02) : 232 - 237
  • [45] Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on megakaryopoiesis of patients with lower risk myelodysplastic syndrome
    Mavroudi, Irene
    Pyrovolaki, Katerina
    Pavlaki, Konstantia
    Kozana, Androniki
    Psyllaki, Maria
    Kalpadakis, Christina
    Pontikoglou, Charalampos
    Papadaki, Helen A.
    LEUKEMIA RESEARCH, 2011, 35 (03) : 323 - 328
  • [46] Phase 2 randomised trial, repurposing Danazol and VBaP in low-risk myelodysplastic syndrome: REPAIR MDS
    Raghavan, Manoj
    Jenkins, Stephen
    Wintrich, Sophie
    Drayson, Mark
    Bunce, Chris
    Culligan, Dominic
    Kulasekararaj, Austin
    Wiseman, Dan
    Foster, Bethany
    Dunn, Janet
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 153 - 153
  • [47] Phase 2 randomised trial, repurposing Danazol and VBaP in low-risk myelodysplastic syndrome: REPAIR MDS
    Raghavan, Manoj
    Jenkins, Stephen
    Wintrich, Sophie
    Drayson, Mark
    Bunce, Chris
    Culligan, Dominic
    Kulasekararaj, Austin
    Wiseman, Dan
    Foster, Bethany
    Dunn, Janet
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 153 - 153
  • [48] Excessive apoptosis in low risk myelodysplastic syndromes (MDS)
    Parker, JE
    Mufti, GJ
    LEUKEMIA & LYMPHOMA, 2000, 40 (1-2) : 1 - 24
  • [49] Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload
    Ivars, David
    Teresa Orero, Maria
    Javier, Karla
    Diaz-Vico, Laura
    Luis Garcia-Gimenez, Jose
    Mena, Salvador
    Tormos, Carmen
    Egea, Mercedes
    Luis Perez, Pedro
    Arrizabalaga, Beatriz
    Angeles Ruiz, Maria
    Yague, Nuria
    Tormo, Mar
    Sancho-Tello, Reyes
    Gomes, Angela
    Alguero, Carmen
    Enrique O'Connor, Jose
    Saez, Guillermo T.
    Carbonell, Felix
    Collado, Rosa
    CLINICAL BIOCHEMISTRY, 2017, 50 (16-17) : 911 - 917
  • [50] Clinical and Biological Characterization of Patients with Low/Intermediate-1 Risk Myelodysplastic Syndrome and Iron Overload
    Ivars, David
    Collado, Rosa
    Alguero, Carmen
    Carmen Tormos, M.
    Diaz, Laura
    Luis Garcia-Ghnenez, Jose
    Arrizabalaga, Beatriz
    Orero, Mayte
    Perez, Pedro
    Sanchez, Magdalena
    Angeles Ruiz, M.
    Yaguee, Nuria
    Sancho-Tello, Reyes
    Regadera, Ana
    Tormo, Mar
    Egea, Mercedes
    Vidal, Elena
    Enrique O'Connor, J.
    Saez, Guillermo T.
    Carbonell, Felix
    BLOOD, 2012, 120 (21)
12345